[fusion_imageframe image_id=”6296″ style_type=”none” stylecolor=”” hover_type=”none” bordersize=”” bordercolor=”” borderradius=”” align=”center” lightbox=”no” gallery_id=”” lightbox_image=”” alt=”Image of Top 10 Banner” link=”” linktarget=”_self” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” animation_type=”” animation_direction=”left” animation_speed=”0.3″ animation_offset=””]https://www.cellmedicine.com/wp-content/uploads/2019/01/Top-10-600×285.jpeg[/fusion_imageframe]
Congratulations to Dr. Riordan and everyone at Stem Cell Institute and Medistem Labs in Panama!
Multiple Sclerosis News Today published its Top 10 Multiple Sclerosis Stories of 2018 and named Stem Cell Institute’s MS clinical trial its #4 top MS story of 2018.
The name of the article that reached #4 is “Treatment with Umbilical Cord Stem Cells Safe with Sustained Benefits for MS, Trial Shows”
The original peer-reviewed article, entitled “Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis” is published in the Journal of Translational Medicine and can be viewed here: https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1433-7
